BioCryst Pharmaceuticals BCRX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $156.41M-61.5% | $406.56M+155% | $159.4M-2.4% | $163.35M+12.2% | $145.53M+10.6% | ||
| $5.38M-43.5% | $9.52M+335% | $2.19M-21.8% | $2.8M-38.7% | $4.57M-25.0% | ||
| $151.04M-62.0% | $397.03M+153% | $157.21M-2.1% | $160.56M+13.9% | $140.97M+12.4% | ||
| 96.6%-1.1pp | 97.7%-1.0pp | 98.6%+0.3pp | 98.3%+1.4pp | 96.9%+1.5pp | ||
| $60.32M+47.6% | $40.87M-8.4% | $44.6M+2.8% | $43.39M+16.4% | $37.27M-24.6% | ||
| $94.55M-1.3% | $95.78M+15.4% | $83.01M-5.0% | $87.38M+6.0% | $82.47M+2.4% | ||
| $16.03M-32.6% | $23.79M+27.9% | $18.6M-12.7% | $21.3M-0.3% | $21.37M+0.1% | ||
| $706K+71.8% | $411K-21.9% | $526K0.0% | $526K-3.3% | $544K-2.9% | ||
| —— | $0— | $0— | $0— | $0— | ||
| —— | 0%— | —— | —— | —— | ||
| $858.01M+487% | $146.17M+12.6% | $129.8M-2.8% | $133.57M+7.4% | $124.31M-8.6% | ||
| -$701.6M-369% | $260.39M+780% | $29.59M-0.7% | $29.79M+40.3% | $21.23M+571% | ||
| -448.6%-513pp | 64%+45.5pp | 18.6%+0.3pp | 18.2%+3.6pp | 14.6%+18.0pp | ||
| $19.78M+39.9% | $14.14M-28.1% | $19.66M-8.9% | $21.58M-8.1% | $23.49M-3.9% | ||
| $2.26M-21.9% | $2.89M+29.1% | $2.24M-11.0% | $2.52M-16.8% | $3.02M-15.3% | ||
| -$19.21M-55.3% | -$12.37M+29.2% | -$17.46M+25.1% | -$23.3M-13.8% | -$20.47M+4.7% | ||
| -$720.81M-391% | $248.02M+1,945% | $12.13M+87.0% | $6.49M+756% | $758K+103% | ||
| $1M-53.8% | $2.17M+382% | -$769K-155% | $1.4M+93.0% | $726K-9.7% | ||
| -$721.81M-394% | $245.85M+1,806% | $12.9M+154% | $5.09M+15,791% | $32K+100% | ||
| -461.5%-522pp | 60.5%+52.4pp | 8.1%+5.0pp | 3.1%+3.1pp | 0%+20.4pp | ||
| -$2.98-364% | $1.13+1,783% | $0.06+200% | $0.02— | $0.00+100% | ||
| -$2.98-355% | $1.17+1,850% | $0.06+200% | $0.02— | $0.00+100% | ||
| 242.3M+10.8% | 218.6M-0.6% | 219.9M0.0% | 219.9M+2.1% | 215.3M+4.1% | ||
| 242.3M+15.4% | 209.9M-0.1% | 210.2M+0.3% | 209.5M+0.3% | 208.9M+1.1% | ||
| $697.76M— | —— | —— | —— | $0— | ||
| —— | —— | —— | —— | $56K— | ||
| —— | -$639.5K0.0% | -$639.5K0.0% | -$639.5K0.0% | -$639.5K— | ||
| -$637K-224% | $512.5K0.0% | $512.5K0.0% | $512.5K0.0% | $512.5K— | ||
| $16.03M-32.7% | $23.82M+27.8% | $18.64M-12.5% | $21.3M-0.3% | $21.37M+0.1% | ||
| $149K— | —— | —— | —— | $544K— | ||
| $600K— | —— | —— | —— | $0— | ||
| $251K+123% | -$1.09M-54.3% | -$707K+38.5% | -$1.15M+16.8% | -$1.38M+49.9% | ||
| 50.8M+58.4% | 32.1M— | —— | —— | 32M-41.2% | ||
| $608K— | —— | —— | $1.07M— | $0— | ||
| $82.04M— | —— | —— | —— | $558K— | ||
| -$722.22M-395% | $244.74M+1,875% | $12.39M+121% | $5.6M+2,204% | $243K+101% | ||
| —— | $0— | $0— | $0— | $0— | ||
| —— | $310K0.0% | $310K0.0% | $310K0.0% | $310K+6.6% | ||
| —— | $875.5K0.0% | $875.5K0.0% | $875.5K0.0% | $875.5K+213% | ||
| —— | $0— | $0— | $0— | $0— | ||
| —— | -$257K0.0% | -$257K0.0% | -$257K0.0% | -$257K-137% | ||
| —— | -$303K0.0% | -$303K0.0% | -$303K0.0% | -$303K-242% | ||
| —— | -$46K0.0% | -$46K0.0% | -$46K0.0% | -$46K-333% | ||
| —— | $1.44M0.0% | $1.44M0.0% | $1.44M0.0% | $1.44M-4.5% | ||
| $461K— | —— | —— | —— | $331K— | ||
| -$72K— | —— | —— | $1.36M+201% | $451K+135% | ||
| —— | $00.0% | $00.0% | $00.0% | $0+150% | ||
| —— | 21%— | —— | —— | —— | ||
| —— | -20%— | —— | —— | —— | ||
| —— | $0— | $0— | $0— | $0+100% | ||
| —— | $966.75K0.0% | $966.75K0.0% | $966.75K0.0% | $966.75K— | ||
| —— | 1%— | —— | —— | —— | ||
| —— | 2%— | —— | —— | —— | ||
| —— | 1%— | —— | —— | —— | ||
| —— | 0%— | —— | —— | —— | ||
| —— | -$893.5K0.0% | -$893.5K0.0% | -$893.5K0.0% | -$893.5K-42.2% | ||
| —— | 0%— | —— | —— | —— | ||
| —— | -1%— | —— | —— | —— | ||
| —— | $4.39M0.0% | $4.39M0.0% | $4.39M0.0% | $4.39M— | ||
| -$2.81M— | —— | —— | —— | $0— | ||
| $3.44M— | —— | —— | —— | —— | ||
| -$971K— | —— | —— | —— | —— | ||
| $64K-11.1% | $72K-14.3% | $84K-6.7% | $90K-4.3% | $94K+10.6% | ||
| $345K-18.6% | $424K-17.3% | $513K-4.3% | $536K+3.9% | $516K+44.9% | ||
| $377K-18.0% | $460K-15.9% | $547K-1.3% | $554K+3.0% | $538K+10.2% | ||
| $441K-17.1% | $532K-15.7% | $631K-2.0% | $644K+1.9% | $632K+10.3% | ||
| -$225K-80.0% | -$125K-457% | $35K+156% | -$63K-6,400% | $1K+100% | ||
| —— | $891.5K0.0% | $891.5K0.0% | $891.5K0.0% | $891.5K— | ||
| —— | $43.16M0.0% | $43.16M0.0% | $43.16M0.0% | $43.16M+376% | ||
| —— | $23.69M0.0% | $23.69M0.0% | $23.69M0.0% | $23.69M+488% | ||
| —— | $0— | $0— | $0— | $0— | ||
| —— | -$13.11M0.0% | -$13.11M0.0% | -$13.11M0.0% | -$13.11M-703% | ||
| —— | $14.04M0.0% | $14.04M0.0% | $14.04M0.0% | $14.04M+408% | ||
| —— | $321.25K0.0% | $321.25K0.0% | $321.25K0.0% | $321.25K+42.9% | ||
| —— | $1.21M0.0% | $1.21M0.0% | $1.21M0.0% | $1.21M+74.0% | ||
| —— | $1.23M0.0% | $1.23M0.0% | $1.23M0.0% | $1.23M+4,705% | ||
| —— | $642.25K0.0% | $642.25K0.0% | $642.25K0.0% | $642.25K+169% | ||
| —— | -$54.25K0.0% | -$54.25K0.0% | -$54.25K0.0% | -$54.25K-161% | ||
| —— | $330.75K0.0% | $330.75K0.0% | $330.75K0.0% | $330.75K-25.0% | ||
| $1.43M— | —— | —— | —— | $1K-99.8% | ||
| -$60.4M-271% | $35.36M+43.9% | $24.58M-19.3% | $30.46M+193% | -$32.59M-260% | ||
| -$749K— | —— | —— | —— | $0— | ||
| $4.85M+841% | $515K-69.6% | $1.69M+218% | -$1.44M-265% | $870K-59.8% | ||
| -$3.53M-282% | $1.94M-67.3% | $5.92M+3,799% | -$160K-221% | $132K+123% | ||
| $474K-96.9% | $15.49M+91,041% | $17K-99.8% | $7.31M-47.8% | $13.99M+91.7% | ||
| -$8.47M-164% | $13.19M-28.0% | $18.32M-64.4% | $51.47M+454% | -$14.55M-164% | ||
| 0-100% | 19K-17.4% | 23K-32.4% | 34K+100% | 17K— | ||
| 0-100% | 3.8M-18.2% | 4.7M+17.4% | 4M+103% | 2M— | ||
| $0— | —— | $5.02M-21.0% | $6.36M+44.5% | $4.4M— | ||
| $2.26M-21.9% | $2.89M+29.1% | $2.24M-11.0% | $2.52M-16.8% | $3.02M-15.3% | ||
| $6.08M+543% | $946K-84.5% | $6.11M-18.8% | $7.53M-17.8% | $9.15M-9.7% | ||
| $8.47M-35.8% | $13.19M-28.0% | $18.32M-18.1% | $22.37M+53.8% | $14.55M-36.3% | ||
| $74K— | $0-100% | $30K-96.3% | $817K+291% | $209K— | ||
| —— | —— | —— | —— | —— | ||
| $412.55M+289% | -$217.96M-271% | -$58.81M+20.2% | -$73.69M-14,029% | $529K+113% | ||
| -$268.65M-222% | -$83.49M-715% | $13.57M-53.4% | $29.13M+7.5% | $27.1M+52.2% | ||
| -$61.79M-121% | $291.96M+601% | $41.62M+0.8% | $41.3M+250% | -$27.52M-428% | ||
| $13.29M-0.2% | $13.32M+3.1% | $12.92M-3.6% | $13.4M-0.8% | $13.51M+0.1% | ||
| 1— | —— | —— | —— | 1+300% | ||
| 1— | —— | —— | —— | 1+300% | ||
| $706K+71.8% | $411K-21.9% | $526K0.0% | $526K-3.3% | $544K-2.9% | ||
| $405K+240% | $119K-73.2% | $444K-14.3% | $518K+34.5% | $385K-9.4% | ||
| -$62K+94.9% | -$1.22M-133% | -$523K-175% | $702K+91.8% | $366K+139% | ||
| -$344K— | —— | $17K+109% | -$188K-21.3% | -$155K— | ||
| -$406K+63.2% | -$1.1M-118% | -$506K-198% | $514K+144% | $211K+115% | ||
| -$1.46M— | —— | —— | —— | $0— | ||
| —— | $3.88M0.0% | $3.88M0.0% | $3.88M0.0% | $3.88M— | ||
| $5.72M+2,636% | $209K0.0% | $209K0.0% | $209K0.0% | $209K+3,383% | ||
| $4.95M— | —— | —— | —— | $0— | ||
| $1.19M-80.2% | $6M+856% | $628K-27.5% | $866K-35.9% | $1.35M-56.2% | ||
| $0-100% | $125.5M+114% | $58.63M+99.8% | $29.34M-39.8% | $48.76M+23.4% | ||
| $489.48M— | —— | —— | —— | $0— | ||
| $403K-49.8% | $802K-40.3% | $1.34M+651% | $179K+25.2% | $143K-78.8% | ||
| —— | -$1.55M0.0% | -$1.55M0.0% | -$1.55M0.0% | -$1.55M— | ||
| $400M— | —— | —— | —— | $0— | ||
| $19.48M+2,865% | $657K-75.2% | $2.65M-22.6% | $3.42M+43.1% | $2.39M— | ||
| $221.24M+352% | $49M-32.9% | $73M+24.5% | $58.65M-22.8% | $76M+31.0% | ||
| $33K— | —— | —— | —— | $6K— | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $476K-92.7% | $6.48M-48.0% | $12.45M+215% | $3.96M— | $0— | ||
| $0— | $0-100% | $26K-84.2% | $165K-75.7% | $679K+20.6% | ||
| $4.2M— | $0-100% | $86K-47.9% | $165K+43.5% | $115K-35.0% | ||
| -$31.48M— | —— | —— | —— | -$26.33M-81.0% | ||
| $971K— | —— | —— | —— | —— | ||
| $16.03M-32.6% | $23.79M+27.9% | $18.6M-12.7% | $21.3M-0.3% | $21.37M+0.1% | ||
| $3.58M— | —— | —— | —— | —— | ||
| $16.03M-32.7% | $23.82M+27.8% | $18.64M-12.5% | $21.3M-0.3% | $21.37M+0.1% | ||
| $251.66M— | —— | —— | —— | —— | ||
| $1.11M— | —— | $1.08M— | —— | $1.22M— | ||
| —— | —— | —— | —— | —— | ||
| $33K+43.5% | $23K+9.5% | $21K+133% | $9K+50.0% | $6K+20.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $18.37M+1,004% | $1.66M+6.2% | $1.57M-54.2% | $3.42M+178% | $1.23M+1,105% | ||
| —— | $0— | $0— | $0— | $0— | ||
| —— | $150.75K0.0% | $150.75K0.0% | $150.75K0.0% | $150.75K— | ||
| —— | $96.5K0.0% | $96.5K0.0% | $96.5K0.0% | $96.5K+9.3% | ||
| —— | -$17.06M0.0% | -$17.06M0.0% | -$17.06M0.0% | -$17.06M-686% | ||
| $0— | —— | $9.71M-6.3% | $10.37M+62.5% | $6.38M— | ||
| $3.17M— | —— | —— | $67K-75.7% | $276K-46.2% | ||
| -$701.6M-369% | $260.39M+780% | $29.59M-0.7% | $29.79M+40.3% | $21.23M+571% | ||
| -$700.54M-369% | $260.78M+771% | $29.93M-0.6% | $30.12M+39.7% | $21.56M+613% | ||
| -$700.54M-369% | $260.78M+771% | $29.93M-0.6% | $30.12M+39.7% | $21.56M+613% | ||
| -447.9%-512pp | 64.1%+45.4pp | 18.8%+0.3pp | 18.4%+3.6pp | 14.8%+18.0pp | ||
| -$701.6M-369% | $260.39M+780% | $29.59M-0.7% | $29.79M+40.3% | $21.23M+571% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is BioCryst Pharmaceuticals's revenue?
- BioCryst Pharmaceuticals (BCRX) generated $885.7M in revenue over the trailing twelve months, up 75.9% year over year.
- Is BioCryst Pharmaceuticals profitable?
- BioCryst Pharmaceuticals is not currently profitable: it reported a net loss of $458.0M over the trailing twelve months, a -51.7% net margin.
- What are BioCryst Pharmaceuticals's profit margins?
- Gross margin is 97.8% and operating margin is -43.1%, with a -51.7% net margin.
- What is BioCryst Pharmaceuticals's earnings per share?
- BioCryst Pharmaceuticals's diluted EPS over the trailing twelve months is $-1.77.
- Where does BioCryst Pharmaceuticals's income statement data come from?
- Every line is extracted from BioCryst Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
